WPRIM Management System> DCMS> Korean Journal of Clinical Pharmacy> 2022> 32> 3

Volume: 32 Issue: 3

1. Development of Eligibility Criteria for Comprehensive Medication Management Programs in Long-term Care Facilities Using RAND/UCLA Appropriateness Method Page:260—269
2. Resuscitation Fluids for Patients at High Risk of Multiple Organ Dysfunction Syndromes: A Systematic Review and Meta-analysis Page:251—259
3. Impact of ABCB1 C3435T Polymorphism on Treatment Response of Vitamin K Antagonists: A Systematic Review and Meta-analysis Page:238—250
4. Identifying the Patterns of Adverse Drug Responses of Cetuximab Page:226—237
5. Cost Avoidance and Clinical Pharmacist Interventions on Hospitalized Patients in Hematologic malignancies Page:215—225
6. Real-world Adverse Events Associated with Fluconazole and Itraconazole:Analysis of Nationwide Data Using a Spontaneous Reporting System Database Page:204—214
7. Assessing the Effectiveness and Safety of Direct-acting Antiviral Treatment in Korean Patients with Hepatitis C Virus Genotype 1b or 2 at a Tertiary Care Hospital Page:191—203
8. Evaluation of Clinical Outcomes by Therapeutic Dosing Interval of Denosumab (Prolia ® ) and Calcium-Vitamin D Prescriptions Page:185—190
9. Medication Prescribing Status in Pediatric Patients with Migraine Page:178—184
10. The Effect of Regulation on Recruitment Advertising for Clinical Trial Subjects in Korea Page:166—177
11. Analysis of Treatment Pattern in COPD Patients Using Health Insurance Claims Data:Focusing on Inhaled Medications Page:155—165

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.